Precise 3D Surview

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global

About this trial

The purpose of the study is to assess the performance of Precise 3D Surview on CT 5300 and Incisive CT Scanners as compared with manual annotation by experienced CT technologists.

* To evaluate the acceptance rate of the Auto 3D Planning Box compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of the Auto Suggestion for Locator compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of the Auto Planning for Truncated Anatomies (lung and liver) compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of Auto Planning and Symmetry Correction for Tilted Head compared with manual annotation by experienced CT technologists.

Eligibility criteria

Qualifiers

Subjects scanned by CT 5300 (K232491) and Incisive CT (K212441) according to the department standard of care clinical protocols.

Subjects age is over eighteen (18) years1.

Patients scanned in supine orientation.

Non-contrast CT scan

Disqualifiers

Subjects age is under or equal 18 years old

Patients are not scanned in supine orientation.

Contrast-enhanced CT scans.

CT scans with high resolution

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Philips Clinical & Medical Affairs Global

Lead sponsor

Philips Healthcare (Suzhou) Co., Ltd.

Collaborator